BRPI0922132A2 - fragmentos glutamil trna sintetase (gts). - Google Patents

fragmentos glutamil trna sintetase (gts).

Info

Publication number: BRPI0922132A2
Authority: BR; Brazil
Prior art keywords: gts; trna synthetase; synthetase fragments; glutamyl trna; glutamyl
Prior art date: 2008-12-03

Application number

BRPI0922132A

Other languages

English (en)

Inventor

Tal Michael

Dagan Ron

Mizrachinebenzahl Yaffa

Original Assignee

Protea Vaccine Tech Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-12-03

Filing date

2009-12-03

Publication date

2018-10-23

2009-12-03 Application filed by Protea Vaccine Tech Ltd filed Critical Protea Vaccine Tech Ltd

2018-10-23 Publication of BRPI0922132A2 publication Critical patent/BRPI0922132A2/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)

BRPI0922132A 2008-12-03 2009-12-03 fragmentos glutamil trna sintetase (gts). BRPI0922132A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11938308P	2008-12-03	2008-12-03
PCT/IL2009/001142 WO2010064243A1 (en)	2008-12-03	2009-12-03	GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS

Publications (1)

Publication Number	Publication Date
BRPI0922132A2 true BRPI0922132A2 (pt)	2018-10-23

Family

ID=42041695

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0922132A BRPI0922132A2 (pt)	2008-12-03	2009-12-03	fragmentos glutamil trna sintetase (gts).

Country Status (9)

Country	Link
US (1)	US20110236470A1 (pt)
EP (1)	EP2356225A1 (pt)
JP (1)	JP2012510289A (pt)
KR (1)	KR20110091560A (pt)
CN (1)	CN102239253A (pt)
AU (1)	AU2009323682A1 (pt)
BR (1)	BRPI0922132A2 (pt)
CA (1)	CA2745205A1 (pt)
WO (1)	WO2010064243A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120076813A1 (en) *	2008-12-03	2012-03-29	Ben Gurion University Of The Negev Research And De Velopment Authority	USES OF GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
RU2580299C2 (ru)	2009-06-29	2016-04-10	Дженосеа Биосайенсиз, Инк.	Вакцины и композиции, направленные против streptococcus pneumoniae
CN103096909A (zh) *	2010-05-04	2013-05-08	Atyr医药公司	与谷氨酰-脯氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
WO2012100233A1 (en)	2011-01-20	2012-07-26	Genocea Biosciences, Inc.	Vaccines and compositions against streptococcus pneumoniae
US9107906B1 (en)	2014-10-28	2015-08-18	Adma Biologics, Inc.	Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en)	2017-03-15	2019-04-16	Adma Biologics, Inc.	Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
KR20220082558A (ko) *	2020-12-10	2022-06-17	재단법인 의약바이오컨버젼스연구단	면역 증진 활성이 있는 신규 crs 단편 펩타이드 및 이의 용도
EP4412709A4 (en) *	2021-10-04	2025-08-13	Agresearch Ltd	NEMATODE VACCINE

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4767842A (en)	1973-05-07	1988-08-30	The Ohio State University	Antigenic modification of polypeptides
US4436727A (en)	1982-05-26	1984-03-13	Ribi Immunochem Research, Inc.	Refined detoxified endotoxin product
US4539205A (en)	1982-11-09	1985-09-03	Scripps Clinic And Research Foundation	Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4643992A (en)	1982-11-09	1987-02-17	Scripps Clinic And Research Foundation	Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5093318A (en)	1983-11-01	1992-03-03	Scripps Clinic And Research Foundation	Immunostimulating guanosine derivatives and their pharmaceutical compositions
US5011828A (en)	1985-11-15	1991-04-30	Michael Goodman	Immunostimulating guanine derivatives, compositions and methods
US5057540A (en)	1987-05-29	1991-10-15	Cambridge Biotech Corporation	Saponin adjuvant
CA2017507C (en)	1989-05-25	1996-11-12	Gary Van Nest	Adjuvant formulation comprising a submicron oil droplet emulsion
US5709879A (en)	1990-06-29	1998-01-20	Chiron Corporation	Vaccine compositions containing liposomes
CA2138997C (en)	1992-06-25	2003-06-03	Jean-Paul Prieels	Vaccine composition containing adjuvants
US5776468A (en)	1993-03-23	1998-07-07	Smithkline Beecham Biologicals (S.A.)	Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A
GB9326253D0 (en)	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
EP1167379A3 (en)	1994-07-15	2004-09-08	University Of Iowa Research Foundation	Immunomodulatory oligonucleotides
UA56132C2 (uk)	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
RS50101B (sr)	1996-02-24	2009-01-22	Boehringer Ingelheim International Gmbh.,	Farmaceutski preparati za imunomodulaciju
US5976840A (en)	1997-04-18	1999-11-02	Smithkline Beecham Corporation	Polynucleotides encoding gluS polypeptides of streptococcal pneumoniae
GB9607992D0 (en)	1996-04-18	1996-06-19	Smithkline Beecham Plc	Novel compounds
US5958734A (en)	1997-04-18	1999-09-28	Smithkline Beecham Corporation	Polynucleotides encoding gluS polypeptides of streptococcus pneumoniae
US6303347B1 (en)	1997-05-08	2001-10-16	Corixa Corporation	Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6355257B1 (en)	1997-05-08	2002-03-12	Corixa Corporation	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6113918A (en)	1997-05-08	2000-09-05	Ribi Immunochem Research, Inc.	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US7063967B2 (en)	1997-05-08	2006-06-20	Corixa Corporation	Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6080725A (en)	1997-05-20	2000-06-27	Galenica Pharmaceuticals, Inc.	Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
DE69828507T2 (de)	1997-05-20	2006-01-05	Galenica Pharmaceuticals, Inc.	Triterpene-saponin analoga mit adjuvans und immunostimulierender wirkung
AU1145699A (en)	1997-09-05	1999-03-22	Smithkline Beecham Biologicals (Sa)	Oil in water emulsions containing saponins
WO1999030737A1 (en)	1997-12-16	1999-06-24	Chiron Corporation	Use of microparticles combined with submicron oil-in-water emulsions
WO1999052549A1 (en)	1998-04-09	1999-10-21	Smithkline Beecham Biologicals S.A.	Adjuvant compositions
NZ508013A (en)	1998-05-07	2003-08-29	Corixa Corp	Adjuvant composition for use with an antigen in a vaccine composition
GB0107658D0 (en)	2001-03-27	2001-05-16	Chiron Spa	Streptococcus pneumoniae
EP2275122A3 (en) *	2002-04-02	2011-05-18	Ben Gurion University Of The Negev Research And Development Authority	Protein-based streptococcus pneumoniae vaccines

2009
- 2009-12-03 BR BRPI0922132A patent/BRPI0922132A2/pt not_active Application Discontinuation
- 2009-12-03 US US13/131,595 patent/US20110236470A1/en not_active Abandoned
- 2009-12-03 EP EP09798968A patent/EP2356225A1/en not_active Withdrawn
- 2009-12-03 JP JP2011539174A patent/JP2012510289A/ja active Pending
- 2009-12-03 AU AU2009323682A patent/AU2009323682A1/en not_active Abandoned
- 2009-12-03 CA CA2745205A patent/CA2745205A1/en not_active Abandoned
- 2009-12-03 CN CN2009801484409A patent/CN102239253A/zh active Pending
- 2009-12-03 WO PCT/IL2009/001142 patent/WO2010064243A1/en not_active Ceased
- 2009-12-03 KR KR1020117014752A patent/KR20110091560A/ko not_active Withdrawn

Also Published As

Publication number	Publication date
KR20110091560A (ko)	2011-08-11
CA2745205A1 (en)	2010-06-10
CN102239253A (zh)	2011-11-09
JP2012510289A (ja)	2012-05-10
WO2010064243A1 (en)	2010-06-10
EP2356225A1 (en)	2011-08-17
AU2009323682A1 (en)	2010-06-10
US20110236470A1 (en)	2011-09-29

Legal Events

Date	Code	Title	Description
2018-10-30	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2019-01-15	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]

Publication	Publication Date	Title
BRPI1010653A2 (pt)	2016-03-15	refrigerador.
BRPI1007047A2 (pt)	2015-08-18	Biorrefino irganosolv de cana-de-açúcar inteira.
BRPI1011275A2 (pt)	2016-03-22	refrigerador.
HUE055338T2 (hu)	2021-11-29	Indolamin-2,3-dioxigenáz-alapú immunterápia
FR2929502B1 (fr)	2011-04-08	Implant nucleique.
BRPI1014650A2 (pt)	2016-04-12	molas espiral-em-espiral e molas interiores.
BRPI0912260A2 (pt)	2015-10-06	tonalizador.
BRPI1010579A2 (pt)	2016-03-15	espiro-oxetano nucleosídeos de uracila.
BRPI1016117A8 (pt)	2018-01-02	derivados de isoxazol-isoxazol e isoxazol-isotiazol.
BRPI0924633A2 (pt)	2016-03-08	refrigerador.
IT1396487B1 (it)	2012-12-14	Convogliatore.
BRPI0922132A2 (pt)	2018-10-23	fragmentos glutamil trna sintetase (gts).
BR112012001062A2 (pt)	2018-03-13	laminados com microtextura.
FR2942517B1 (fr)	2015-07-03	Materiau compliant.
BRPI1016192A2 (pt)	2016-04-19	derivados de soxazol.
DK2442870T3 (da)	2014-06-30	Pyrazinooxazepin-derivater.
IT1394665B1 (it)	2012-07-13	Granitore.
FR2950402B1 (fr)	2011-10-21	Collier de serrage.
BRPI0907448A2 (pt)	2015-07-14	Instrumentos.
BR112012002612A2 (pt)	2018-03-13	calha.
BRPI1008952A2 (pt)	2015-09-01	Composição herbicida.
BRPI0922477A2 (pt)	2015-12-15	transportador.
IT1396642B1 (it)	2012-12-14	Statore.
IT1396781B1 (it)	2012-12-14	Piano di cottura.
BR112012000911A2 (pt)	2016-11-22	biomarcador.